Sign In  |  Register  |  About Santa Clara  |  Contact Us

Santa Clara, CA
September 01, 2020 1:39pm
7-Day Forecast | Traffic

  • Search Hotels in Santa Clara

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Gilead Sciences (NQ: GILD )

92.38 +0.04 (+0.04%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 11, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Gilead Sciences

< Previous 1 2
...
10 11 12 13 14 15 16 17 Next >
2020 R&D Spending and Intensity Benchmarks
VIRGINIA BEACH, Va. - June 1, 2021 - PRLog -- According to a newly released study from Schonfeld & Associates, Inc., R&D Ratios & Budgets, now in its 45th annual edition, the pharmaceutical industry... 
Via PRLog
Topics Supply Chain
Exposures Supply Chain
New Study: Coronavirus Vaccine Market Forecast to 2026 : Serum Institute of India ,BioNTech SE ,Pfizer Inc. ,Gilead Sciences Inc.
Edison, NJ -- (SBWIRE) -- 05/25/2021 -- Advance Market Analytics published a new research publication on "Coronavirus Vaccine Market Insights, to 2026" with 232 pages and enriched with self-explained... 
Via SBWire
Exposures COVID-19
A Comprehensive Study Exploring Covid-19 Therapeutic Market : Key Players AstraZeneca, Novartis, Ascletis Pharma, Pharmstandard
The Latest survey report on Global Covid-19 Therapeutic Market sheds lights on changing dynamics of each of the subsegments of Industry. As the shift to value continues, Covid-19 Therapeutic... 
Via SBWire
Exposures COVID-19
A Workplace for Tomorrow
SOURCE: Gilead Sciences 
Via 3BL Media
Exposures COVID-19
Four Questions With Wayne Duffus: Addressing Health Disparities in HIV Prevention and Care
SOURCE: Gilead Sciences 
Via 3BL Media
MODERN BLK GIRL Launches Channel and Pays Teens to Build Wealth
Via Get News
Gilead-Kite Oncology to Present Transformative Science From Growing Portfolio at ASCO 2021
From Gilead Sciences, Inc.
Via Business Wire
Gilead Sciences to Present at Upcoming Investor Conferences
From Gilead Sciences, Inc.
Via Business Wire
Antiviral Drugs Market Is Going to Boom : Roche, Merck, Novartis, Johnson & Johnson
The Global Antiviral Drugs Market survey analysis offers energetic visions to conclude and study market size, market hopes and competitive surroundings. 
Via SBWire
Entheon Biomedical Corp. Provides Corporate Update
Launch of Psychedelics DNA Test KitPhase 1 clinical trial for DMT progressing as plannedPre-clinical In Vivo work scheduled to start... 
Via Newsfile
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
Gilead Presents: Episode 5 - Assuring Possible
SOURCE: Gilead Sciences 
Via 3BL Media
Gilead Sciences Supports CuriOdyssey's New Regional Education Initiative for BIPOC Youth
Gilead Sciences granted $500K to launch CuriOdyssey STEMCorps, a new, comprehensive education initiative for youth from the Asian American, Pacific Islander, Latinx, Hispanic, Black, and Indigenous... 
Via Newswire.com
Lacing Up for Health After Beating COVID-19: Paulo's Story
SOURCE: Gilead Sciences 
Via 3BL Media
Topics Product Recall
Exposures COVID-19 Legal Product Safety
Gilead Sciences to Present at Upcoming Investor Conferences
From Gilead Sciences, Inc.
Via Business Wire
Gilead and Kite Present: Episode 4 - Delivering Possible
SOURCE: Gilead Sciences 
Via 3BL Media
Exposures COVID-19
A Letter from Daniel O'Day, Our Chairman and Chief Executive Officer: A Year In Review
SOURCE: Gilead Sciences 
Via 3BL Media
Topics Climate Change
Exposures COVID-19 Climate
Gilead Sciences Announces Second Quarter 2021 Dividend
From Gilead Sciences, Inc.
Via Business Wire
Gilead Sciences Announces First Quarter 2021 Financial Results
From Gilead Sciences, Inc.
Via Business Wire
Protein Engineering Market Size, Share, Industry Growth, Trend, Business Opportunities, Challenges, Drivers and Restraint Research Report by 2027
Protein Engineering market was valued at USD 1.86 billion in 2019 and is expected to reach USD 4.77 billion by the year 2027, at a CAGR of 12.3%. 
Via SBWire
Exposures COVID-19
Bright Pink Honors ChangeMakers Taking Action to Support Health Equity
ChangeMakers Debuts Online May 25 Supporting Women’s Health by Ensuring Information and Access for All. Register here https://brightpink.org/change/ 
Via EIN Presswire
Gilead Presents: Episode 3 - Championing Possible
SOURCE: Gilead Sciences 
Via 3BL Media
Dr. Plammoottil V. Cherian's New Book 'Christ Over Virus, Iniquities, and Death' Gives a Closer Look Into the Relationship Between Science and Theology
Recent release "Christ Over Virus, Iniquities, and Death" from Covenant Books author Plammoottil V. Cherian, M.Div., PhD unveils an in-depth study into the current issues, present world cultures, and... 
Via Newswire.com
Topics Religion
Exposures COVID-19 Religion
Gilead Sciences Announces Steps to Expand Availability of Remdesivir in India
From Gilead Sciences, Inc.
Via Business Wire
Renowned Attorney Ben Crump Looks to Help Victims Settle Lawsuits Against Truvada
April 27, 2021 -- Manufacturer failed to warn about kidney and bone risks of the HIV prevention drug 
Via 24-7 Press Release
Topics Lawsuit
Exposures Financial Legal
“Upgrade The Dental Experience” With Dr. Justin Dugas At Dugas Dental & Carr Orthodontics, #1 Rated Dentist Office in Lewis Center, OH
Via Get News
Gilead Presents: Episode 2 - Realizing Possible
SOURCE: Gilead Sciences 
Via 3BL Media
Exposures COVID-19
Gilead Presents: Episode 1 - Defining Possible
SOURCE: Gilead Sciences 
Via 3BL Media
Exposures COVID-19
Gilead Sciences to Release First Quarter 2021 Financial Results on Thursday, April 29, 2021
From Gilead Sciences, Inc.
Via Business Wire
U.S. FDA Grants Accelerated Approval to Trodelvy® for the Treatment of Metastatic Urothelial Cancer
From Gilead Sciences, Inc.
Via Business Wire
Cell and Gene Therapy Market Overview, Size, Share, Growth, Business Scenario, Insights, Industry Analysis, Trends and Forecasts Report 2027
Vancouver, BC -- (SBWIRE) -- 04/13/2021 -- Cell and Gene Therapy Market Size – USD 1,180.0 Million in 2019, Cell and Gene Therapy Market Growth - CAGR of 19.8%, Cell and Gene Therapy Industry Trends... 
Via SBWire
Exposures COVID-19
< Previous 1 2
...
10 11 12 13 14 15 16 17 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 SantaClara.com & California Media Partners, LLC. All rights reserved.